XML 126 R108.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Guarantor Information Condensed Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Condensed Financial Statements, Captions [Line Items]                      
Cash provided by (used in) activities of continuing operations                 $ 148,709 $ 91,880 $ 20,108
Cash provided by (used in) activities of discontinued operations                 0 0 (2,690)
Cash provided by (used in) operating activities $ 67,289 $ 79,464 $ 9,947 $ (7,991) $ 39,295 $ 41,996 $ 26,435 $ (15,846) 148,709 91,880 17,418
Capital expenditures (37,393) $ (22,996) $ (16,682) (22,208) (20,907) $ (30,678) $ (20,749) (27,438) (99,279) (99,772) (140,787)
Proceeds from the sale of assets                 5,529 1,033 577
Purchase of investments                 (2,500) (5,023) (426)
Sale of investments                 30,831 2,109 12,713
Payments to Acquire Businesses, Net of Cash Acquired                 0 0 (6,914)
Proceeds from notes receivable                 0 7,168 19,000
Other                 (252) 1,919 11
Investments in consolidated subsidiaries                 0 0 0
Cash provided by (used in) activities of continuing operations                 (65,671) (92,566) (101,998)
Cash provided by (used in) activities of discontinued operations                 0 0 (28,470)
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES                 (65,671) (92,566) (130,468)
Proceeds from Issuance of Common Stock                 0 123,059 0
Issuance of notes and bank borrowings, net of issuance costs                 150,000 60,000 95,000
Payments on debt, capital leases, and associated costs                 (175,984) (221,854) (95,059)
Payment for Contingent Consideration Liability, Financing Activities                 (18,750) (18,697) 0
Net intercompany financing activity                 0 0 0
Other                 (1,801) (3,404) (5,160)
Cash provided by (used in) activities of continuing operations                 (46,535) (60,896) (5,219)
Cash provided by (used in) activities of discontinued operations                 0 0 (22)
Cash provided by (used in) activities of discontinued operations                 (46,535) (60,896) (5,241)
Effect of exchange rate changes on cash and cash equivalents                 649 531 28
Less net cash provided by (used in) discontinued operations                 0 0 (32,930)
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH                 37,152 (61,051) (85,333)
Cash, cash equivalents and restricted cash at beginning of period       57,018       118,069 57,018 118,069 203,402
Cash, cash equivalents and restricted cash at end of period 94,170       57,018       94,170 57,018 118,069
Eliminations                      
Condensed Financial Statements, Captions [Line Items]                      
Cash provided by (used in) activities of continuing operations                   324,068 (2,911)
Cash provided by (used in) activities of discontinued operations                 0 0 0
Cash provided by (used in) operating activities                 (60,313) 324,068 (2,911)
Capital expenditures                 0 0 0
Proceeds from the sale of assets                 0 0 0
Purchase of investments                 0 0 0
Sale of investments                 0 0 0
Payments to Acquire Businesses, Net of Cash Acquired                     0
Proceeds from notes receivable                   0 0
Other                 0 0 0
Investments in consolidated subsidiaries                 60,313 (324,068) 2,911
Cash provided by (used in) activities of continuing operations                     2,911
Cash provided by (used in) activities of discontinued operations                 0 0 0
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES                 60,313 (324,068) 2,911
Proceeds from Issuance of Common Stock                   0  
Issuance of notes and bank borrowings, net of issuance costs                 0 0 0
Payments on debt, capital leases, and associated costs                 0 0 0
Payment for Contingent Consideration Liability, Financing Activities                 0 0  
Net intercompany financing activity                 0 0 0
Other                 0 0 0
Cash provided by (used in) activities of continuing operations                 0 0 0
Cash provided by (used in) activities of discontinued operations                 0 0 0
Cash provided by (used in) activities of discontinued operations                 0 0 0
Effect of exchange rate changes on cash and cash equivalents                 0 0 0
Less net cash provided by (used in) discontinued operations                 0 0 0
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH                 0 0 0
Cash, cash equivalents and restricted cash at beginning of period       0       0 0 0 0
Cash, cash equivalents and restricted cash at end of period 0       0       0 0 0
Coeur Mining, Inc.                      
Condensed Financial Statements, Captions [Line Items]                      
Cash provided by (used in) activities of continuing operations                   (377,159) (45,313)
Cash provided by (used in) activities of discontinued operations                 0 0 0
Cash provided by (used in) operating activities                 16,926 (377,159) (45,313)
Capital expenditures                 (317) (491) (390)
Proceeds from the sale of assets                 4,500 0 23
Purchase of investments                 (2,500) (5,019) (431)
Sale of investments                 30,831 2,109 11,694
Payments to Acquire Businesses, Net of Cash Acquired                     0
Proceeds from notes receivable                   7,168 19,000
Other                 0 2,051 46
Investments in consolidated subsidiaries                 (60,888) 323,561 (6,288)
Cash provided by (used in) activities of continuing operations                     23,654
Cash provided by (used in) activities of discontinued operations                 0 0 0
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES                 (28,374) 329,379 23,654
Proceeds from Issuance of Common Stock                   123,059  
Issuance of notes and bank borrowings, net of issuance costs                 150,000 60,000 95,000
Payments on debt, capital leases, and associated costs                 (150,000) (195,878) (60,826)
Payment for Contingent Consideration Liability, Financing Activities                 0 0  
Net intercompany financing activity                 22,988 55,611 (50,640)
Other                 (1,801) (3,404) (5,160)
Cash provided by (used in) activities of continuing operations                 21,187 39,388 (21,626)
Cash provided by (used in) activities of discontinued operations                 0 0 0
Cash provided by (used in) activities of discontinued operations                 21,187 39,388 (21,626)
Effect of exchange rate changes on cash and cash equivalents                 8 0 0
Less net cash provided by (used in) discontinued operations                 0 0 0
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH                 9,747 (8,392) (43,285)
Cash, cash equivalents and restricted cash at beginning of period       4,356       12,748 4,356 12,748 56,033
Cash, cash equivalents and restricted cash at end of period 14,103       4,356       14,103 4,356 12,748
Guarantor Subsidiaries                      
Condensed Financial Statements, Captions [Line Items]                      
Cash provided by (used in) activities of continuing operations                   125,325 55,656
Cash provided by (used in) activities of discontinued operations                 0 0 0
Cash provided by (used in) operating activities                 135,576 125,325 55,656
Capital expenditures                 (60,306) (48,324) (58,040)
Proceeds from the sale of assets                 792 913 446
Purchase of investments                 0 (1) 0
Sale of investments                 0 0 1,019
Payments to Acquire Businesses, Net of Cash Acquired                     0
Proceeds from notes receivable                   0 0
Other                 0 32 217
Investments in consolidated subsidiaries                 (38) 180 159
Cash provided by (used in) activities of continuing operations                     (56,199)
Cash provided by (used in) activities of discontinued operations                 0 0 0
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES                 (59,552) (47,200) (56,199)
Proceeds from Issuance of Common Stock                   0  
Issuance of notes and bank borrowings, net of issuance costs                 0 0 0
Payments on debt, capital leases, and associated costs                 (15,621) (17,364) (12,239)
Payment for Contingent Consideration Liability, Financing Activities                 0 0  
Net intercompany financing activity                 (59,103) (59,068) (13,906)
Other                 0 0 0
Cash provided by (used in) activities of continuing operations                 (74,724) (76,432) (26,145)
Cash provided by (used in) activities of discontinued operations                 0 0 0
Cash provided by (used in) activities of discontinued operations                 (74,724) (76,432) (26,145)
Effect of exchange rate changes on cash and cash equivalents                 2 (2) (11)
Less net cash provided by (used in) discontinued operations                 0 0 0
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH                 1,302 1,691 (26,699)
Cash, cash equivalents and restricted cash at beginning of period       27,231       25,540 27,231 25,540 52,239
Cash, cash equivalents and restricted cash at end of period 28,533       27,231       28,533 27,231 25,540
Non-Guarantor Subsidiaries                      
Condensed Financial Statements, Captions [Line Items]                      
Cash provided by (used in) activities of continuing operations                   19,646 12,676
Cash provided by (used in) activities of discontinued operations                 0 (2,690)
Cash provided by (used in) operating activities                 56,520 19,646 9,986
Capital expenditures                 (38,656) (50,957) (82,357)
Proceeds from the sale of assets                 237 120 108
Purchase of investments                 0 (3) 5
Sale of investments                 0 0 0
Payments to Acquire Businesses, Net of Cash Acquired                     (6,914)
Proceeds from notes receivable                   0 0
Other                 (252) (164) (252)
Investments in consolidated subsidiaries                 613 327 3,218
Cash provided by (used in) activities of continuing operations                     (72,364)
Cash provided by (used in) activities of discontinued operations                 0 0 (28,470)
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES                 (38,058) (50,677) (100,834)
Proceeds from Issuance of Common Stock                   0  
Issuance of notes and bank borrowings, net of issuance costs                 0 0 0
Payments on debt, capital leases, and associated costs                 (10,363) (8,612) (21,994)
Payment for Contingent Consideration Liability, Financing Activities                 (18,750) (18,697)  
Net intercompany financing activity                 36,115 3,457 64,546
Other                 0 0 0
Cash provided by (used in) activities of continuing operations                 7,002 (23,852) 42,552
Cash provided by (used in) activities of discontinued operations                 0 0 (22)
Cash provided by (used in) activities of discontinued operations                 7,002 (23,852) 42,530
Effect of exchange rate changes on cash and cash equivalents                 639 533 39
Less net cash provided by (used in) discontinued operations                 0 0 (32,930)
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH                 26,103 (54,350) (15,349)
Cash, cash equivalents and restricted cash at beginning of period       $ 25,431       $ 79,781 25,431 79,781 95,130
Cash, cash equivalents and restricted cash at end of period $ 51,534       $ 25,431       $ 51,534 $ 25,431 $ 79,781